Literature DB >> 11397344

The duration of major depressive episodes in the Canadian general population.

S C Patten1.   

Abstract

The National Population Health Survey (NPHS) has provided a wealth of new data concerning major depression in the Canadian general population. The NPHS included a brief predictor of major depression, and also two questions (only one of which was asked of each subject) concerned with the duration of episodes in the preceding year. A striking finding was that many of the episodes identified were very brief. In this paper the NPHS data were examined from a different perspective in order to derive a complementary perspective on the episode duration data. Data from the 1994/95 and 1996/97 cycles of the NPHS were used in the analysis. The longitudinal data were used to generate approximations of age and gender-specific incidence for members of the population over the age of 12 years. An estimate of prevalence was made from the 1996/97 cross-sectional file. A basic expression relating prevalence to incidence and mean duration of illness was then applied within age and gender categories. Taken together, the incidence and prevalence data from the NPHS suggest a longer duration than was indicated by the NPHS interview duration item. A probable explanation is that the NPHS duration question had an upper limit of 52 weeks, whereas some episodes of major depression last longer than this. Particularly long episodes could have a large impact on mean duration in the population. Nevertheless, these data confirm the heterogenous nature of this condition; many people with the syndrome of major depression may have quite brief episodes.

Entities:  

Mesh:

Year:  2001        PMID: 11397344

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  4 in total

1.  Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

Review 2.  Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-11-13

3.  The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010.

Authors:  Alize J Ferrari; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Scott B Patten; Theo Vos; Harvey A Whiteford
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

4.  Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study.

Authors:  Carlotta Lunghi; Jocelyne Moisan; Jean-Pierre Grégoire; Line Guénette
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.